Haleon Other Current Assets 2023-2024 | HLN

Haleon other current assets from 2023 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Haleon other current assets for the quarter ending September 30, 2024 were $0M, a 100% decline year-over-year.
  • Haleon other current assets for 2024 were $0.166B, a 68.13% decline from 2023.
  • Haleon other current assets for 2023 were $0.521B, a 742.74% increase from 2022.
  • Haleon other current assets for 2022 were $0.062B, a 0% decline from 2021.
Haleon Annual Other Current Assets
(Millions of US $)
2024 $166
2023 $521
2022 $62
2021 $0
Haleon Quarterly Other Current Assets
(Millions of US $)
2024-09-30
2024-03-31
2023-09-30
2023-03-31
2022-12-31 $62
2022-06-30 $173
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $48.124B $14.355B
Haleon plc engages in the research and development, manufacture and sale of various consumer healthcare products principally in North America, Europe, the Middle East, Africa, Latin America and the Asia Pacific. It provides therapeutic oral health, pain relief, respiratory health, digestive health and other products, as well as vitamins, minerals and supplements. Haleon plc is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.503B 27.84
Boston Scientific (BSX) United States $154.040B 38.56
Stryker (SYK) United States $144.095B 30.13
EssilorLuxottica (ESLOY) France $132.622B 0.00
Medtronic (MDT) Ireland $105.579B 15.42
Lonza Group Ag (LZAGY) Switzerland $51.866B 0.00
ResMed (RMD) United States $35.477B 26.65
GE HealthCare Technologies (GEHC) United States $30.720B 14.59
Agilent Technologies (A) United States $30.004B 19.82
Terumo (TRUMY) Japan $29.197B 0.00
Koninklijke Philips (PHG) Netherlands $22.643B 16.28
Zimmer Biomet Holdings (ZBH) United States $18.255B 11.72
Insulet (PODD) United States $18.215B 77.74
Baxter (BAX) United States $15.352B 11.47
Smith & Nephew SNATS (SNN) United Kingdom $12.456B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $7.970B 0.00
Lantheus Holdings (LNTH) United States $7.179B 17.65
Bio-Rad Laboratories (BIO) United States $6.487B 21.93
Prestige Consumer Healthcare (PBH) United States $4.014B 19.16
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Perrigo (PRGO) Ireland $3.368B 9.64
ICU Medical (ICUI) United States $3.306B 28.16
Haemonetics (HAE) United States $3.194B 15.03
Envista Holdings (NVST) United States $2.778B 23.08
GN Store Nord (GNNDY) Denmark $2.069B 17.14
LeMaitre Vascular (LMAT) United States $1.855B 41.46
QuidelOrtho (QDEL) United States $1.750B 14.65
AtriCure (ATRC) United States $1.478B 0.00
Green Thumb Industries (GTBIF) United States $1.281B 20.17
AdaptHealth (AHCO) United States $1.194B 12.12
Neogen (NEOG) United States $1.192B 15.25
Kestra Medical Technologies (KMTS) United States $1.139B 0.00
BioLife Solutions (BLFS) United States $1.043B 0.00
InMode (INMD) Israel $0.995B 9.11
Phibro Animal Health (PAHC) United States $0.771B 11.83
Evolus (EOLS) United States $0.749B 0.00
Owens & Minor (OMI) United States $0.596B 5.07
Curaleaf Holdings (CURLF) Canada $0.579B 0.00
CeriBell (CBLL) United States $0.568B 0.00
Valneva SE (VALN) France $0.542B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.518B 0.00
Tilray Brands (TLRY) Canada $0.424B 0.00
Cresco Labs (CRLBF) United States $0.420B 0.00
Surmodics (SRDX) United States $0.391B 0.00
Omeros (OMER) United States $0.370B 0.00
SNDL (SNDL) Canada $0.344B 0.00
VAREX IMAGING (VREX) United States $0.340B 14.75
Capricor Therapeutics (CAPR) United States $0.333B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Verano Holdings (VRNOF) United States $0.302B 0.00
Viemed Healthcare (VMD) United States $0.292B 26.43
Sanara MedTech (SMTI) United States $0.283B 0.00
Sanuwave Health (SNWV) United States $0.262B 0.00
Aurora Cannabis (ACB) Canada $0.259B 46.10
ZimVie (ZIMV) United States $0.245B 14.65
Cerus (CERS) United States $0.239B 0.00
Canopy Growth (CGC) Canada $0.235B 0.00
OraSure Technologies (OSUR) United States $0.217B 0.00
Quanterix (QTRX) United States $0.208B 0.00
High Tide (HITI) Canada $0.192B 0.00
Biote (BTMD) United States $0.184B 4.21
Utah Medical Products (UTMD) United States $0.176B 14.16
TriSalus Life Sciences (TLSI) United States $0.166B 0.00
Brainsway (BWAY) Israel $0.162B 50.65
Organigram Global (OGI) Canada $0.147B 0.00
FitLife Brands (FTLF) United States $0.146B 17.99
Jin Medical (ZJYL) China $0.130B 0.00
TerrAscend (TSNDF) Canada $0.117B 0.00
Exagen (XGN) United States $0.116B 0.00
Agape ATP (ATPC) $0.103B 0.00
MacroGenics (MGNX) United States $0.093B 0.00
Quipt Home Medical (QIPT) United States $0.091B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Jushi Holdings (JUSHF) United States $0.086B 0.00
Fonar (FONR) United States $0.076B 10.58
Veru (VERU) United States $0.074B 0.00
InterCure (INCR) Israel $0.073B 0.00
Zynex (ZYXI) United States $0.061B 0.00
United Health Products (UEEC) United States $0.059B 0.00
Cytosorbents (CTSO) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Apyx Medical (APYX) United States $0.040B 0.00
Rockwell Medical (RMTI) United States $0.038B 55.50
Safety Shot (SHOT) United States $0.037B 0.00
United-Guardian (UG) United States $0.036B 11.14
Nephros (NEPH) United States $0.019B 0.00
INLIF (INLF) $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00